Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL‐17 signaling pathway gene LCN2 in castration‐resistant prostate cancer
暂无分享,去创建一个
Rucheng Yan | Weiwei Dai | Guopeng Yu | Bin Xu | Wenfeng Li | Y. Mao | Minfeng Shu
[1] N. Jiang,et al. Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer , 2022, Cell Death & Disease.
[2] Y. Kuwahara,et al. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability. , 2022, Life sciences.
[3] Rucheng Yan,et al. Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. , 2022, Cancer letters.
[4] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[5] R. Weiskirchen,et al. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3 , 2022, Cells.
[6] Li Ma,et al. A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis , 2021, Nature Communications.
[7] A. Bansal,et al. The m6A reader IMP2 directs autoimmune inflammation through an IL-17– and TNFα-dependent C/EBP transcription factor axis , 2021, Science Immunology.
[8] J. K. Badawi. Bee Venom Components as Therapeutic Tools against Prostate Cancer , 2021, Toxins.
[9] T. H. van der Kwast,et al. Prostate cancer , 2021, Nature Reviews Disease Primers.
[10] Shih-Ying Wu,et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung , 2021, Nature Communications.
[11] M. Staege,et al. Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells , 2020, International journal of molecular sciences.
[12] Fang Zuo,et al. LCN2 Mediated by IL-17 Affects the Proliferation, Migration, Invasion and Cell Cycle of Gastric Cancer Cells by Targeting SLPI , 2020, Cancer management and research.
[13] Henk G van der Poel,et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. , 2020, European urology.
[14] Diwei Ho,et al. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer , 2020, npj Precision Oncology.
[15] P. Scheet,et al. Augmented Lipocalin-2 is Associated with COPD and Counteracts Lung Adenocarcinoma Development. , 2020, American journal of respiratory and critical care medicine.
[16] D. Pe’er,et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis , 2020, Science.
[17] P. Vivas-Mejia,et al. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer , 2020, International journal of molecular sciences.
[18] Q. Luo,et al. Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response , 2020, Nature Communications.
[19] G. Stark,et al. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis , 2020, Nature Communications.
[20] R. Chen,et al. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 , 2019, Cell Death & Disease.
[21] P. Nelson,et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. , 2019, The Journal of clinical investigation.
[22] S. Gaffen,et al. IL-17 receptor–based signaling and implications for disease , 2019, Nature Immunology.
[23] Y. Kuwahara,et al. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells. , 2019, Life sciences.
[24] H. Bae,et al. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide , 2019, Journal of Immunotherapy for Cancer.
[25] Zhihong Zhang,et al. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis , 2019, Nature Communications.
[26] G. Tonon,et al. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression , 2018, Nature Communications.
[27] David F Jarrard,et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] H. Mukhtar,et al. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. , 2017, Cancer letters.
[29] S. Yang,et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition , 2016, Oncogene.
[30] H. Kashima,et al. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells , 2016, PloS one.
[31] F. Separovic,et al. Model Membrane and Cell Studies of Antimicrobial Activity of Melittin Analogues. , 2015, Current topics in medicinal chemistry.
[32] V. Adam,et al. Perspective of Use of Antiviral Peptides against Influenza Virus , 2015, Viruses.
[33] J. Jonkers,et al. IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.
[34] M. Rubin,et al. Aggressive Variants of Castration-Resistant Prostate Cancer , 2014, Clinical Cancer Research.
[35] T. Souto-Padrón,et al. Melittin peptide kills Trypanosoma cruzi parasites by inducing different cell death pathways. , 2013, Toxicon : official journal of the International Society on Toxinology.
[36] P. Thall,et al. Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer , 2013, Clinical Cancer Research.
[37] H. Hudnell,et al. Chronic biotoxin-associated illness: multiple-system symptoms, a vision deficit, and effective treatment. , 2005, Neurotoxicology and teratology.
[38] Thomas,et al. The Structure of Melittin , 2001 .
[39] W. Shi,et al. Antimicrobial peptide melittin against Xanthomonas oryzae pv. oryzae, the bacterial leaf blight pathogen in rice , 2016, Applied Microbiology and Biotechnology.